VanEck Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Buy |
296,480
+1,895
| +0.6% | +$52.3K | 0.01% | 550 |
|
|
2025
Q1 | $8.35M | Buy |
294,585
+31,173
| +12% | +$884K | 0.01% | 537 |
|
|
2024
Q4 | $11M | Sell |
263,412
-3,517
| -1% | -$146K | 0.01% | 443 |
|
|
2024
Q3 | $14.3M | Buy |
266,929
+114,769
| +75% | +$6.13M | 0.02% | 375 |
|
|
2024
Q2 | $18.1M | Sell |
152,160
-81,086
| -35% | -$9.63M | 0.03% | 300 |
|
|
2024
Q1 | $24.9M | Sell |
233,246
-37,528
| -14% | -$4M | 0.04% | 240 |
|
|
2023
Q4 | $26.9M | Buy |
270,774
+43,646
| +19% | +$4.34M | 0.05% | 201 |
|
|
2023
Q3 | $23.5M | Buy |
227,128
+24,698
| +12% | +$2.55M | 0.05% | 211 |
|
|
2023
Q2 | $24.6M | Buy |
202,430
+9,552
| +5% | +$1.16M | 0.05% | 211 |
|
|
2023
Q1 | $29.6M | Buy |
192,878
+15,285
| +9% | +$2.35M | 0.07% | 192 |
|
|
2022
Q4 | $31.9M | Sell |
177,593
-31,887
| -15% | -$5.73M | 0.08% | 182 |
|
|
2022
Q3 | $24.8M | Buy |
209,480
+13,342
| +7% | +$1.58M | 0.07% | 197 |
|
|
2022
Q2 | $28M | Sell |
196,138
-102,523
| -34% | -$14.6M | 0.07% | 208 |
|
|
2022
Q1 | $51.4M | Buy |
298,661
+965
| +0.3% | +$166K | 0.11% | 174 |
|
|
2021
Q4 | $75.6M | Buy |
297,696
+105,382
| +55% | +$26.8M | 0.17% | 132 |
|
|
2021
Q3 | $74M | Buy |
192,314
+36,282
| +23% | +$14M | 0.19% | 129 |
|
|
2021
Q2 | $36.7M | Sell |
156,032
-68,988
| -31% | -$16.2M | 0.09% | 190 |
|
|
2021
Q1 | $29.5M | Buy |
225,020
+54,419
| +32% | +$7.13M | 0.08% | 185 |
|
|
2020
Q4 | $17.8M | Sell |
170,601
-181,467
| -52% | -$19M | 0.05% | 219 |
|
|
2020
Q3 | $24.9M | Sell |
352,068
-12,554
| -3% | -$888K | 0.08% | 157 |
|
|
2020
Q2 | $23.4M | Sell |
364,622
-85,492
| -19% | -$5.49M | 0.08% | 166 |
|
|
2020
Q1 | $13.5M | Buy |
+450,114
| New | +$13.5M | 0.07% | 181 |
|